0
0
4/27/23 at 6:39pm
Organization
CNBC
Author
Kevin Stankiewicz
42 words
0
Comments
Eli Lilly (LLY) made up for a first-quarter earnings miss with a raised outlook and positive obesity-trial data for a potential blockbuster drug.
You are the first to view
https://www.cnbc.com/2023/04/27/club-name-eli-lilly-is-set-for-a-solid-2023.html
Create an account
or login to join the discussion